1. Lemp, M. A. et al. The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye WorkShop. Ocul. Surf. 5, 75–92 (2007).
2. Pflugfelder, S. C. & de Paiva, C. S. The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research. Ophthalmology 124, S4–S13 (2017).
3. Yamaguchi, T. Inflammatory response in dry eye. Investig. Ophthalmol. Vis. Sci. 59, DES192–DES199 (2018).
4. Pflugfelder, S. C., De Paiva, C. S., Villarreal, A. L. & Stern, M. E. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-β2 production. Cornea 27, 64–69 (2008).
5. Pflugfelder, S. C. & Stern, M. E. Mucosal environmental sensors in the pathogenesis of dry eye. Expert Rev. Clin. Immunol. 10, 1137–1140 (2014).
6. Arantxa, A., Germán, R., Elena, V., Isabel, L. & Juan A, D. Inflammatory markers in the tears of patients with ocular surface disease. Ophthalmic Res 40, 315–321 (2008).
7. Ralph, R. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest Ophthalmol 14, 299–302 (1975).
8. Tseng, S. et al. Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology 91, 545–552 (1984).
9. Nelson, J. & Wright, J. Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 102, 1049–1051 (1984).
10. Coursey, T. G. et al. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 10, 743–756 (2017).
11. Pflugfelder, S. C. et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am. J. Pathol. 166, 61–71 (2005).
12. De Paiva, C. et al. IL-17 disrupts corneal barrier following desiccating stress. 2, 243–253 (2013).
13. Wang, C. et al. Dysbiosis modulates ocular surface inflammatory response to liposaccharide. Investig. Ophthalmol. Vis. Sci. 60, (2019).
14. Zárate-Bladés, C. R. et al. Gut microbiota as a source of a surrogate antigen that triggers autoimmunity in an immune privileged site. Gut Microbes 8, 1–8 (2017).
15. Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 1–12 (2014).
16. Sjögren, K. et al. The gut microbiota regulates bone mass in mice. J. Bone Miner. Res. 27, 1357–67 (2012).
17. Lobel, L., Cao, Y. G., Fenn, K., Glickman, J. N. & Garrett, W. S. Diet posttranslationally modifies the mouse gut microbial proteome to modulate renal function. Science (80-. ). 369, 1518–1524 (2020).
18. Theiler, A. et al. Butyrate ameliorates allergic airway inflammation by limiting eosinophil trafficking and survival. J. Allergy Clin. Immunol. 144, 764–776 (2019).
19. Prakash, A. et al. Lung Ischemia-Reperfusion is a Sterile Inflammatory Process Influenced by Commensal Microbiota in Mice. Shock 44, 272–279 (2015).
20. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
21. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
22. Telesford, K. M. et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39+Foxp3+ T cells and Treg function. Gut Microbes 6, 234–242 (2015).
23. Round, J. L. & Mazmanian, S. K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U. S. A. 107, 12204–12209 (2010).
24. Round, J. L. & Mazmanian, S. K. The gut microbiome shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323 (2014).
25. Macpherson, A. & Harris, N. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478–85 (2004).
26. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507–510 (2008).
27. Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science (80-. ). 313, 1126–1130 (2006).
28. Kugadas, A., Wright, Q., Geddes-McAlister, J. & Gadjeva, M. Role of microbiota in strengthening ocular mucosal barrier function through secretory IgA. Investig. Ophthalmol. Vis. Sci. 58, 4593–4600 (2017).
29. Kugadas, A. et al. Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS Pathog. 12, 1–24 (2016).
30. De Paiva, C. S. et al. Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome. Sci. Rep. 6, 23561 (2016).
31. Wang, C. et al. Sjögren-like lacrimal Keratoconjunctivitis in germ-free mice. Int. J. Mol. Sci. 19, 10–15 (2018).
32. Zaheer, M. et al. Protective role of commensal bacteria in Sjögren Syndrome. J. Autoimmun. 93, 45–56 (2018).
33. Tyagi, A. M. et al. The Microbial Metabolite Butyrate Stimulates Bone Formation via T Regulatory Cell-Mediated Regulation of WNT10B Expression. Immunity 49, 1116-1131.e7 (2018).
34. Takahashi, D. et al. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells. EBioMedicine 58, 1–5 (2020).
35. Hoffman, J. D. et al. Dietary inulin alters the gut microbiome, enhances systemic metabolism and reduces neuroinflammation in an APOE4 mouse model. PLoS One 14, 1–22 (2019).
36. Matt, S. M. et al. Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice. Front. Immunol. 9, (2018).
37. Gambhir, D. et al. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 53, 2208–2217 (2012).
38. Nakamura, Y. K. et al. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci. Rep. 7, 1–12 (2017).
39. Chen, X. et al. Sodium butyrate regulates Th17/Treg cell balance to ameliorate uveitis via the Nrf2/HO-1 pathway. Biochem. Pharmacol. 142, 111–119 (2017).
40. Venegas, D. P. et al. Short chain fatty acids (SCFAs)mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front. Immunol. 10, (2019).
41. Schulthess, J. et al. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity 50, 432–445 (2019).
42. Bian, F. et al. Inhibition of NLRP3 Inflammasome Pathway by Butyrate Improves Corneal Wound Healing in Corneal Alkali Burn. Int. J. Mol. Sci. 18, 562 (2017).
43. Frank, H. et al. Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice. J. Biol. Chem. 283, 24729–24737 (2008).
44. Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 18, e3000411 (2020).
45. Moore, Q. L., De Paiva, C. S. & Pflugfelder, S. C. Effects of dry eye therapies on environmentally induced ocular surface disease. Am. J. Ophthalmol. 160, 135-142.e1 (2015).
46. Simmons, K. T., Xiao, Y., Pflugfelder, S. C. & de Paiva, C. S. Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model. Investig. Opthalmology Vis. Sci. 57, 2443 (2016).
47. Rodriguez, A. et al. Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87, 3500–3503 (2002).
48. Sivaprakasam, S., Bhutia, Y. D., Yang, S. & Ganapathy, V. Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis. Compr Physiol 8, 299–314 (2018).
49. Zimmerman, M. A. et al. Butyrate suppresses colonic inflammation through HDAC1-dependent fas upregulation and fas-mediated apoptosis of T cells. Am. J. Physiol. - Gastrointest. Liver Physiol. 302, 1405–1415 (2012).
50. Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128–139 (2014).
51. Wang, R. X., Lee, J. S., Campbell, E. L. & Colgan, S. P. Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin. Proc. Natl. Acad. Sci. U. S. A. 117, 11648–11657 (2020).
52. Sivaprakasam, S. et al. Deficiency of Dietary Fiber in Slc5a8 -Null Mice Promotes Bacterial Dysbiosis and Alters Colonic Epithelial Transcriptome towards Proinflammatory Milieu. Can. J. Gastroenterol. Hepatol. 2019, (2019).
53. Hayes, C. L. et al. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci. Rep. 8, 1–14 (2018).
54. Gurav, A. et al. Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty acids, is a conditional tumor suppressor in colon that protects against colitis and colon cancer under low-fiber dietary conditions. Biochem J 469, 267–278 (2015).
55. Zhang, X. et al. Desiccating stress induces CD4 + T-cell-mediated Sjögren’s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-γ. Am. J. Pathol. 179, 1807–1814 (2011).
56. Niederkorn, J. Y. et al. Desiccating Stress Induces T Cell-Mediated Sjögren’s Syndrome-Like Lacrimal Keratoconjunctivitis. J. Immunol. 176, 3950–3957 (2006).
57. De Paiva, C. S. et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ. Investig. Ophthalmol. Vis. Sci. 48, 2553–2560 (2007).
58. Clifford, A. J., Smith, L. M., Creveling, R. K., Hamblin, C. L. & Clifford, C. K. Effects of Dietary Triglycerides on Serum and Liver Lipids and Sterol Excretion of Rats. J. Nutr. 116, 944–956 (1986).
59. Egorin, M. J., Yuan, Z. M., Sentz, D. L., Plaisance, K. & Eiseman, J. L. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother. Pharmacol. 43, 445–453 (1999).
60. Boets, E. et al. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. J. Physiol. 595, 541–555 (2017).
61. Cleophas, M. C. P. et al. Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males. Sci. Rep. 9, 1–10 (2019).
62. Su, J., Zhang, N. & Ho, P. C. Determination of tributyrin and its metabolite butyrate in Wistar rat plasma samples by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 18, 2217–2222 (2004).
63. He, J. et al. Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. Int. J. Mol. Sci. 21, 6356 (2020).
64. Sun, M., Wu, W., Liu, Z. & Cong, Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J. Gastroenterol. 52, 1–8 (2017).
65. Macia, L. et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6, (2015).
66. Vinolo, M. A. R. et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849–855 (2011).
67. Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. U. S. A. 111, 2247–2252 (2014).
68. Smith, P. M. et al. The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis. Science (80-. ). 341, 569–574 (2013).
69. Waldecker, M., Kautenburger, T., Daumann, H., Busch, C. & Schrenk, D. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 19, 587–593 (2008).
70. Wei, J., Jiang, H., Gao, H. & Wang, G. Activation of toll like receptor-3 induces corneal epithelial barrier dysfunction. Biochem. Biophys. Res. Commun. 461, 555–559 (2015).
71. Singh, N. et al. Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases. J. Biol. Chem. 285, 27601–27608 (2010).
72. Chauhan, S. et al. Autoimmunity in Dry Eye is due to Resistance of Th17 to Treg Suppression. J. Immunol. 182, 1247–1252 (2009).